| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 02/02/2011 | EP2279174A2 Arylsulfonamide compounds, compositions and methods of use |
| 02/02/2011 | EP2279173A1 New arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments |
| 02/02/2011 | EP1954679B1 A new intermediate for making montelukast and related compounds |
| 02/02/2011 | EP1904448B1 Purification of montelukast |
| 02/02/2011 | EP1682491B1 Non-symmetrical gelling agent |
| 02/02/2011 | CN101962359A Hapten, artifical antigen and antibody of enrofloxacin and preparation method as well as application thereof |
| 02/02/2011 | CN101962358A Ciprofloxacin hapten, artificial antigen and antibody and preparation method and application thereof |
| 02/01/2011 | US7880006 Quinoline derivatives and insecticide comprising thereof as active ingredient |
| 02/01/2011 | US7880003 Method for making tris (8-hydroxyquinoline) nano-crystal |
| 02/01/2011 | US7879878 Quinolone derivative or salt thereof |
| 02/01/2011 | US7879876 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 02/01/2011 | US7879865 central nervous system disorders; brain cancer; oral administration |
| 02/01/2011 | US7879863 Aniline derivatives |
| 02/01/2011 | US7879857 6-substituted 2-quinolinones and 2-quinoxalinones as poly (adp-ribose) polymerase inhibitors |
| 02/01/2011 | CA2688915C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 02/01/2011 | CA2560547C Formamide derivatives useful as adrenoceptor |
| 02/01/2011 | CA2502633C 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 02/01/2011 | CA2477881C Formoterol superfine formulation |
| 02/01/2011 | CA2320116C 2-aminoquinoline derivatives having d4-agonistic activity |
| 02/01/2011 | CA2286385C Quinoline derivatives, having in particular antiviral properties, preparation and biological applications thereof |
| 01/27/2011 | WO2011009540A2 Pesticidal carboxamides |
| 01/27/2011 | US20110021562 Treatment of friedreich's ataxia using histone deacetylase inhibitors |
| 01/27/2011 | US20110021561 Quinoline compound and pharmaceutical composition, preparation method and uses thereof |
| 01/27/2011 | US20110021540 Bis-(Sulfonylamino) Derivatives in Therapy 066 |
| 01/27/2011 | US20110021528 Novel hydroxamates as therapeutic agents |
| 01/27/2011 | US20110021514 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 01/27/2011 | CA2768787A1 Pesticidal carboxamides |
| 01/26/2011 | EP2277858A1 Amide compound |
| 01/26/2011 | EP2276740A1 Improved process for preparing quinoline-3-carboxamide derivatives |
| 01/26/2011 | EP2276739A1 Process for making montelukast intermediates |
| 01/26/2011 | EP2081907B1 Aryl piperazine derivatives useful for the treatment of neuropsychiatry disorders |
| 01/26/2011 | EP2019825B9 Inhibitors of human immunodeficiency virus replication |
| 01/26/2011 | EP1554239B1 Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists |
| 01/26/2011 | CN101959865A Quinolines as inhibitors of farnesyl pyrophosphate synthase |
| 01/26/2011 | CN101959864A 2-aminoquinoline derivatives |
| 01/26/2011 | CN101959861A Trpa1 antagonists |
| 01/26/2011 | CN101959557A 2-aminoquinolines as 5-HT5A receptor antagonists |
| 01/26/2011 | CN101077875B Boronic ester and acid compounds, synthesis and uses |
| 01/25/2011 | US7875722 Method for producing quinolone carboxylic acid derivative |
| 01/25/2011 | US7875604 Compounds that inhibit HIV particle formation |
| 01/25/2011 | CA2539760C Quinoline potassium channel inhibitors |
| 01/25/2011 | CA2472776C Process for the manufacture of hmg-coa reductase inhibitors |
| 01/25/2011 | CA2404125C Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 01/20/2011 | WO2011009095A1 Crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quin0lin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1, 1-dicarboxamide |
| 01/20/2011 | US20110015399 Stable vinamidinium salt and nitrogen-containing heterocyclic ring synthesis using the same |
| 01/20/2011 | US20110015375 Methods for Identifying and Using MarR Family Polypeptide Binding Compounds |
| 01/20/2011 | US20110015225 Heterocyclic compound |
| 01/20/2011 | US20110015201 Hedgehog pathway antagonists and methods of use |
| 01/20/2011 | US20110015152 Diarylmethyl and related compounds |
| 01/20/2011 | CA2768370A1 Crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1, 1-dicarboxamide |
| 01/19/2011 | EP2275411A2 Reformatsky Reagent in Stable Form and Process for Producing the Same |
| 01/19/2011 | EP2275395A2 Copper-catalyzed formation of carbon-carbon bonds |
| 01/19/2011 | EP2273992A1 Quenolines and related analogs as sirtuin modulators |
| 01/19/2011 | EP1922135B1 Hindered cyclic polyamines and their salts for acid gas scrubbing process |
| 01/19/2011 | CN101949856A Analytical reagent for measuring trace cadmium, preparation method and application thereof |
| 01/19/2011 | CN101948426A New method for preparing aripiprazole crystal form B |
| 01/19/2011 | CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same |
| 01/19/2011 | CN101948366A Method for preparing 4-(diphenylamino)biaryl compound in water phase |
| 01/19/2011 | CN101111249B Chemokine-binding heterocyclic compound salts, and methods of use thereof |
| 01/18/2011 | US7872127 2-(4-(1-methyl-4-piperidinoxy)benzylamino)-2-methyl-propanamide; nervous system disorders; analgesics; anticonvulsants; sodium channel moderators; antidepressants, antiarrhythmics and for the treatment or prevention of diabetic neuropathy |
| 01/18/2011 | US7872126 Tetrahydroquinoline derivatives and a process for preparing the same |
| 01/18/2011 | US7872021 Liver X receptors (LXR) modulators such as 1-[[4-(1,1-dimethylethyl)phenyl]sulfonyl]-4-methoxy-N-(2-phenyl ethyl)-2,3-dihydro-1H-)indole-2-carboxamide, used for the treatment of atherosclerosis, dyslipidemia, obesity, diabetes, hypercholesterolemia, neurodegenerative diseases and inflammatory diseases |
| 01/18/2011 | US7872004 Therapy, propjylxis of aids; side effect reduction |
| 01/18/2011 | US7871773 Aza-benzazolium containing cyanine dyes |
| 01/18/2011 | CA2321881C Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 01/13/2011 | WO2011004389A2 An improved process for the preparation of elvitegravir |
| 01/13/2011 | WO2011004298A1 Montelukast hexamethylenediamine salt and its use for the preparation of montelukast sodium |
| 01/13/2011 | US20110009626 Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 01/13/2011 | US20110009447 Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis |
| 01/12/2011 | EP2272822A1 Inhibitor of plasminogen activator inhibitor-1 |
| 01/12/2011 | EP2272813A2 Copper-catalyzed formation of carbon-oxygen bonds |
| 01/12/2011 | EP2272516A2 4-Oxoquinoline compound and use thereof as HIV integrase inhibitor |
| 01/12/2011 | EP2271343A1 Salts of 2-substituted quinolines |
| 01/12/2011 | EP1682138B1 Heterocyclic inhibitors of mek |
| 01/12/2011 | CN101945839A Method for producing conjugated aromatic compound |
| 01/12/2011 | CN101941941A Carboxylic ester compound and applications thereof |
| 01/12/2011 | CN101941917A Amide compounds and use thereof |
| 01/12/2011 | CN101450927B Benzoic acid derivates containing oxo pyridine substituted propionamido |
| 01/12/2011 | CN101029022B Process for the preparation of 4-phenoxy quinoline derivatives |
| 01/11/2011 | US7868174 Form of a benzenesulfonamide derivative |
| 01/11/2011 | US7868022 Drug for Alzheimer's disease; cognition activators; strokes; down's disease; Parkinson's disease |
| 01/11/2011 | US7868021 Antimicrobial quinolones, their compositions and uses |
| 01/11/2011 | US7868020 Quinolynylmethylimidizoles as therapeutic agents |
| 01/11/2011 | CA2566922C Stable crystal of 4-oxoquinoline compound |
| 01/11/2011 | CA2493287C Process for preparing quinolone antibiotic intermediates |
| 01/11/2011 | CA2461439C Novel .alpha.-oxygenated or .alpha.-thiolated carboxylic acid phenethylamide derivatives |
| 01/11/2011 | CA2422054C Bicyclic heteroaromatic compounds |
| 01/11/2011 | CA2407593C Fused heteroaryl derivatives |
| 01/06/2011 | WO2011002984A1 Substituted phenoxypropylcycloamine derivatives as histamine-3 (h3) receptor ligands |
| 01/06/2011 | WO2011001089A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 01/06/2011 | WO2010111303A3 Imaging agents for detecting neurological disorders |
| 01/06/2011 | WO2010098583A3 Novel method for preparing statin compounds or salts thereof, and intermediate compounds used in same |
| 01/06/2011 | US20110003992 Mono and bis-ester derivatives of pyridinium and quinolinium compounds as environmentally friendly corrosion inhibitors |
| 01/06/2011 | US20110003795 Substituted Aromatic Carboxamide and Urea Derivatives as Vanilloid Receptor Ligands |
| 01/06/2011 | US20110002953 Use of immidazoquinolinamines as adjuvants in dna vaccination |
| 01/06/2011 | CA2766882A1 Therapeutic compounds and compositions |
| 01/06/2011 | CA2764193A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 01/05/2011 | EP2270006A1 Pyridazine derivatives useful as vanilloid receptor ligands |
| 01/05/2011 | EP2269609A2 Treatment of neurodegenerative diseases and cancer of the brain with SAHA |
| 01/05/2011 | EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain |